EE+ POEM Archive
Monitoring ALT, AST, and CBC after initiation of therapy has very low yield for terbinafine or griseofulvin
Monitoring ALT, AST, and CBC after initiation of therapy has very low yield for terbinafine or griseofulvin is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Monitoring ALT, AST, and CBC After Initiation of Therapy Has Very Low Yield for Terbinafine or Griseofulvin." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314798/all/Monitoring_ALT__AST__and_CBC_after_initiation_of_therapy_has_very_low_yield_for_terbinafine_or_griseofulvin.
Monitoring ALT, AST, and CBC after initiation of therapy has very low yield for terbinafine or griseofulvin. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314798/all/Monitoring_ALT__AST__and_CBC_after_initiation_of_therapy_has_very_low_yield_for_terbinafine_or_griseofulvin. Accessed August 3, 2021.
Monitoring ALT, AST, and CBC after initiation of therapy has very low yield for terbinafine or griseofulvin. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314798/all/Monitoring_ALT__AST__and_CBC_after_initiation_of_therapy_has_very_low_yield_for_terbinafine_or_griseofulvin
Monitoring ALT, AST, and CBC After Initiation of Therapy Has Very Low Yield for Terbinafine or Griseofulvin [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2021 August 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314798/all/Monitoring_ALT__AST__and_CBC_after_initiation_of_therapy_has_very_low_yield_for_terbinafine_or_griseofulvin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Monitoring ALT, AST, and CBC after initiation of therapy has very low yield for terbinafine or griseofulvin
ID - 1314798
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314798/all/Monitoring_ALT__AST__and_CBC_after_initiation_of_therapy_has_very_low_yield_for_terbinafine_or_griseofulvin
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
